Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
Insulin degludec/insulin aspart (IDegAsp) is the first soluble co-formulation which combines two insulin analogues, and provides effective basal and prandial glycemic coverage. It has been assessed as basal insulin in type 2 diabetes mellitus (T2DM), and as part of basal-bolus regime in both type 1...
| Main Author: | |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer Healthcare
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065296/ |